Federal Register Notices > Notice of Registration - 2005 >  Abbott Laboratories, DBA Knoll Pharmaceutical Company

Notice of Registration - 2005 

FR Doc 05-16468 [Federal Register: August 19, 2005 (Volume 70, Number 160)] [Notices] [Page 48779] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr19au05-74]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 16, 2005, Abbott Laboratories, DBA Knoll Pharmaceutical Company, 30 North Jefferson Road, Whippany, New Jersey 07981, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II:

The company plans to manufacture bulk product and dosage units for distribution to its customers. 

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). 

Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than October 18, 2005.

Dated: August 11, 2005. 

William J. Walker, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. 

[FR Doc. 05-16468 Filed 8-18-05; 8:45 am]

BILLING CODE 4410-09-P